Experimental drug boosts HDL counts | Science News



Support credible science journalism.

Subscribe to Science News today.


Experimental drug boosts HDL counts

10:49am, April 28, 2004

A novel drug called torcetrapib can dramatically increase blood concentrations of high-density lipoprotein (HDL), the beneficial cholesterol, according to a preliminary study. Derived from a trial involving only 19 people, these data paved the way for two much larger studies that are just under way.

Seventeen men and two women took a torcetrapib pill daily for 4 weeks, then an inert pill for 4 more weeks. Scientists recorded the amount of HDL in the volunteers' blood after each period. Some of the volunteers also completed a third drug regimen, in which they took torcetrapib twice a day.

Nine of the participants took the anticholesterol drug atorvastatin along with torcetrapib.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content